Centene Corp
NYSE:CNC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/E
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Valuation Scenarios
If P/E returns to its 3-Year Average (12.3), the stock would be worth $-167.84 (415% downside from current price).
| Scenario | P/E Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -3.9 | $53.31 |
0%
|
| 3-Year Average | 12.3 | $-167.84 |
-415%
|
| 5-Year Average | 15.1 | $-205.08 |
-485%
|
| Industry Average | 27.6 | $-375.55 |
-804%
|
| Country Average | 22.9 | $-311.27 |
-684%
|
Forward P/E
Today’s price vs future net income
| Today's Market Cap | Net Income | Forward P/E | ||
|---|---|---|---|---|
|
$21.8B
|
/ |
Jan 2026
$-6.7B
|
= |
|
|
$21.8B
|
/ |
Dec 2026
$1.5B
|
= |
|
|
$21.8B
|
/ |
Dec 2027
$2B
|
= |
|
|
$21.8B
|
/ |
Dec 2028
$2.8B
|
= |
|
|
$21.8B
|
/ |
Dec 2029
$3.8B
|
= |
|
|
$21.8B
|
/ |
Dec 2030
$4.8B
|
= |
|
|
$21.8B
|
/ |
Dec 2031
$5.9B
|
= |
|
|
$21.8B
|
/ |
Dec 2032
$7B
|
= |
|
|
$21.8B
|
/ |
Dec 2033
$8.1B
|
= |
|
Forward P/E shows whether today’s P/E still looks high or low once future net income are taken into account.
Peer Comparison
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| US |
|
Centene Corp
NYSE:CNC
|
24.4B USD | -3.9 | |
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
332.9B USD | 27.9 | |
| US |
A
|
Anthem Inc
LSE:0HG8
|
94.6B USD | 18.1 | |
| US |
|
Elevance Health Inc
NYSE:ELV
|
78.8B USD | 15.4 | |
| US |
|
Humana Inc
NYSE:HUM
|
27.7B USD | 24.1 | |
| US |
|
Molina Healthcare Inc
NYSE:MOH
|
9.6B USD | 54.1 | |
| US |
|
Healthequity Inc
NASDAQ:HQY
|
6.9B USD | 32.1 | |
| US |
M
|
Magellan Health Inc
F:MAH1
|
2.2B EUR | 8.5 | |
| BR |
|
Odontoprev SA
BOVESPA:ODPV3
|
8B BRL | 13.9 | |
| US |
|
Progyny Inc
NASDAQ:PGNY
|
1.5B USD | 25.6 | |
| US |
|
Clover Health Investments Corp
NASDAQ:CLOV
|
1.4B USD | -15.5 |
Market Distribution
| Min | 0 |
| 30th Percentile | 15.3 |
| Median | 22.9 |
| 70th Percentile | 33.2 |
| Max | 1 826 183.3 |
Other Multiples
Centene Corp
Glance View
Centene Corporation, a titan in the managed care industry, orchestrates its operations with a focus on government-sponsored healthcare programs. Founded in 1984, Centene swiftly carved its niche by administering Medicaid services, a vital safety net for low-income individuals and families in the United States. The company adeptly navigates the complexities of healthcare delivery by partnering with state governments to provide managed healthcare services, ensuring access to quality care while keeping costs in check. Centene's growth strategy hinges on its expansive network, tailored to meet diverse health needs, including those of the medically underserved. Through strategic acquisitions, such as the pivotal purchase of WellCare Health Plans, Centene has bolstered its market position, broadening its reach across all 50 states. Profiting primarily through capitation arrangements, Centene receives a fixed amount per member from the government in exchange for providing healthcare services. This model incentivizes efficiency and cost containment, as the company retains any cost savings generated. Beyond Medicaid, Centene has diversified its portfolio by delving into Medicare Advantage, Marketplace insurance plans, and international markets, thus ensuring resilience against fluctuations in any single segment. The company's revenue engine is fueled by its ability to strike a balance between quality healthcare delivery and disciplined fiscal management, driven by an insightful understanding of regional healthcare needs and regulatory landscapes. Through this model, Centene not only generates substantial revenue but also strives to positively impact health outcomes, exemplifying its commitment to a mission-driven approach in the ever-evolving healthcare ecosystem.